QUT ePrints

A DRD2 polymorphism predicts PANSS score variability in schizophrenia patients treated with antipsychotics

Voisey, Joanne, Swagell, Christopher D., Hughes, Ian P., Barnes, Mark, Burton, Simon C., van Daal, Angela M., Morris, C. Phillip, Lawford, Bruce R., & Young, Ross McD. (2010) A DRD2 polymorphism predicts PANSS score variability in schizophrenia patients treated with antipsychotics. Psychiatry Research, 177(3), pp. 367-368.

[img] PDF (37Kb)

    View at publisher

    Abstract

    Antipsychotic medications act as either antagonists or partial agonists of the dopamine D2 receptor (DRD2) and antipsychotic drugs vary widely in their binding affinity for the D2 receptor (Kapur and Seeman, 2000). The DRD2 957CNT (rs6277) polymorphism has previously been associated with schizophrenia (Lawford et al., 2005) and the T-allele of the 957CNT polymorphism is associated with reduced mRNA stability and synthesis of the dopamine D2 receptor (Duan et al., 2003). The aim of the study was to determine if
    the rs6277 polymorphism predicts some of the variability of positive and negative symptoms observed in schizophrenia patients being treated with antipsychotic medication.

    Citations:

    0 times in Scopus
    Search Google Scholar™
    0 times in Web of Science

    Citation countsare sourced monthly from Scopus and Web of Science citation databases.

    These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science generally from 1980 onwards.

    Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

    Full-text downloads:

    105 since deposited on 09 Mar 2011
    47 in the past twelve months

    Full-text downloadsdisplays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.

    More statistics...
    ID Code: 40589
    Item Type: Journal Article
    Keywords: Dopamine, Genotype, Psychological Disorder, Medication, Genetics
    DOI: 10.1016/j.psychres.2010.02.015
    ISSN: 0165-1781
    Subjects: Australian and New Zealand Standard Research Classification > BIOLOGICAL SCIENCES (060000) > GENETICS (060400) > Neurogenetics (060410)
    Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > CLINICAL SCIENCES (110300)
    Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > PUBLIC HEALTH AND HEALTH SERVICES (111700) > Mental Health (111714)
    Australian and New Zealand Standard Research Classification > PSYCHOLOGY AND COGNITIVE SCIENCES (170000) > COGNITIVE SCIENCE (170200)
    Divisions: Past > Schools > Cell & Molecular Biosciences
    Current > QUT Faculties and Divisions > Faculty of Health
    Past > QUT Faculties & Divisions > Faculty of Science and Technology
    Current > Institutes > Institute of Health and Biomedical Innovation
    Current > Schools > School of Psychology & Counselling
    Copyright Owner: Copyright © 2010 Elsevier Ltd All rights reserved.
    Deposited On: 09 Mar 2011 11:25
    Last Modified: 19 Jan 2012 15:33

    Export: EndNote | Dublin Core | BibTeX

    Repository Staff Only: item control page